Form 4 for OPK OPKO HEALTH, INC.
Accepted 2024-01-08 00:00:00 ET · period of report 2024-01-04 · accession 0000950170-24-002743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-08 | 2024-01-05 | OPK | HSIAO JANE PH D | CTO, Vice COB, Dir | P - Purchase | $0.87 | +150.0K | 27.85M | +0.5% | +$130.5K |
| D | 2024-01-08 | 2024-01-04 | OPK | HSIAO JANE PH D | CTO, Vice COB, Dir | D - Sale to Iss | — | 0 | 0 | New | — |
| D | 2024-01-08 | 2024-01-04 | OPK | HSIAO JANE PH D | CTO, Vice COB, Dir | A - Grant | — | 0 | 6.45M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-05 | P | A | 150,010 | $0.87 | 27,849,880 | D | — | — | |
| 2 | Derivative | 5% Convertible Notes due 2025 | 2024-01-04 | D | D | — | — | 0 | D | $1.66 · — to 2025-01-31 | — Common Stock | (F2) The 5% Convertible Promissory Notes due 2025 were originally entered into on February 27, 2018 and the Reporting Person had the option to convert all or any portion of the outstanding principal balance of such original notes, plus unpaid interest, into shares of the Issuer's (as defined below) common stock, par value $0.01 per share, at a conversion price of $5.00 per share, at any time prior to the maturity date, which was February 27, 2023. Pursuant to an amendment on February 10, 2023, the maturity date was extended to January 31, 2025, which amendment also reset the conversion price to the 10 day volume weighted average price immediately preceding the date of such amendment, plus a 25% conversion premium, or $1.66. |
| 3 | Derivative | 3.75% Convertible Notes due 2029 | 2024-01-04 | A | A | — | — | 6,452,000 | D | $1.15 · 2028-09-15 to 2029-01-15 | — Common Stock | (F4) The reporting person entered into a Convertible Note Purchase Agreement with OPKO Health, Inc. (the "Issuer") on January 4, 2024, pursuant to which the reporting person disposed of $5,000,000 aggregate principal amount of 5% Convertible Promissory Notes due 2025, and accrued and unpaid interest thereon, in exchange for $6,452,000 aggregate principal amount of the Issuer's 3.75% Convertible Senior Notes due 2029 in a private placement. (F3) Prior to September 15, 2028, holders of the 3.75% Convertible Senior Notes due 2029 will have the right to convert such notes only in certain circumstances and during specified periods and thereafter, will be convertible at the option of the holder at any time prior to the close of business on the business day immediately preceding January 15, 2029, the maturity date. |